ArticlePhysical and engineering sciences in medicine2026
A novel hierarchical transfer learning to enhance breast cancer detection on screening mammography using deep learning.
Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and early detection of breast cancer in screening mammography remains a critical challenge in medical imaging, particularly due to variations in image quality, tissue density, and annotation standards across datasets. This study aims to design and validate a Hierarchical Transfer Learning (HTL) framework that leverages heterogeneous mammography datasets and multi‑stage pre-processing to achieve more accurate and generalizable deep learning-based detection of breast lesions in screening mammography. Our approach integrates five image enhancement techniques, CLAHE, Gamma Correction, Adaptive Histogram Equalization, Global Histogram Equalization, and Unsharp Masking into the learning process, allowing the model to adapt progressively to enhancement specific features. We evaluate the framework using two state-of-the-art object detection architectures, YOLOv8 and Faster R-CNN, across three publicly available datasets (INbreast, CBIS-DDSM, and MIAS) and a locally collected dataset. Our HTL model achieves a peak mean Average Precision (mAP) of 0.981 and accuracy of 0.998, outperforming previous methods in both generalizability and precision. Moreover, the model maintains robust performance on real-world local data, demonstrating its practical utility for deployment in diverse clinical environments. These results confirm that hierarchical learning combined with strategic image enhancement and pre-processing significantly improves detection performance and supports large scale breast cancer screening applications with robust cross-dataset generalization, enabling consistent performance across heterogeneous imaging domains with varying acquisition protocols, image quality, and annotation standards.
Indexed as
Identifiers
42525327What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.